Health Bulletin: Daily COVID-19 Positivity Rate Down To 6.1 Per Cent

The health ministry said that the rate of spread of infection is being effectively contained.

Study Finds A Quarter Of Population Underestimates Their Risk Of Developing Skin Cancer Risk

A study conducted in Queensland has found that almost one fourth of the population underestimates their risk of developing potentially deadly melanomas – with those at highest risk worst at predicting their chances of getting the skin cancers.

The findings have been published in the Journal of Investigative Dermatology. And data from nearly 42,000 Queenslanders who participated in their QSkin study were examined to reach to the conclusion. CLICK HERE TO READ FULL REPORT

Daily COVID-19 Positivity Rate Down To 6.1 Per Cent

The average daily positivity rate of COVID-19 infection has been declining for past five weeks and was at 6.1 per cent during the last week (Oct 14-19), from 9.2 per cent during September 16-22. There has been a drop in the cumulative positivity rate and is at below 8 per cent. It remained so for last four consecutive days.

The health ministry said that the rate of spread of infection is being effectively contained and this is clearly demonstrated from the declining trend in positivity. 8,59,786 samples were tested on Sunday out which report of 55,722 samples came positive for the infection. With this the number of COVID-19 cases in the country has increased to 75,50,273. India has so far conducted over 9.5 crore tests to check Covid-19 infection. CLICK HERE TO READ FULL REPORT

Serum Institute, Bharat Biotech Await Approval For Nasal Vaccine Trials: Centre

Serum Institute of India and Bharat Biotech are waiting for regulatory approval to conduct late-stage clinical trials of an intranasal vaccine for coronavirus. The last state trials with usually thousands of participants are likely to start in a few months, Union Minister Dr Harsh Vardhan said.

It must be noted that no vaccines have so far got approval for commercial use against the COVID-19. However, over a dozen vaccines are being tested on humans across the globe. CLICK HERE TO READ FULL REPORT

Tobacco Is Being Used As A Key Ingredient In Some Coronavirus Vaccines

The tobacco plant is being used by some drug companies as a key ingredient in the development of a coronavirus vaccine.

In recent years, the plant has been given a bad name due to the use of one tobacco strain called Nicotiana tabacum for producing cigarettes. Indigenous people of North America and Alaska have admired the tobacco plant for its use in medicinal practices in addition to using it in spiritual ceremonies. CLICK HERE TO READ FULL REPORT

Need To Continue Extreme Caution Against COVID-19: WHO

The World Health Organization on Monday warned against any relaxation of response actions following the recent slight decline in COVID-19 cases in the South-East Asia Region and said the pandemic continues unabated and our response only needs to be strengthened further to curtail virus transmission.

Dr. Poonam Khetrapal Singh, Regional Director WHO South-East Asia Region said, “There should be no complacency in view of the declining numbers in recent weeks. The Region still reports large numbers of COVID-19 cases. We need to continue to do our very best to curtail the pandemic.” CLICK HERE TO READ FULL REPORT

Facebook Comments